{"schema_version":"secwatch.filing_event.v1","accession":"0001477449-24-000099","form_type":"8-K","ticker":"TDOC","cik":"0001477449","company_name":"Teladoc Health, Inc.","filed_at":"2024-04-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.587820+00:00","generated_at":"2026-06-03T07:50:40.899812+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Teladoc Health Q1 revenue +3% to $646.1M; adjusted EBITDA +20% to $63.1M","bullets":["Revenue $646.1M (+3% YoY); net loss $81.9M ($0.49 EPS) vs $69.2M loss in Q1 2023.","Integrated Care revenue +8% to $377.1M; BetterHelp revenue -4% to $269.0M.","Adjusted EBITDA rose 20% to $63.1M; free cash flow -$26.6M (improved from -$32.5M).","Q2 2024 outlook: revenue $635-660M, adj. EBITDA $70-80M, net loss per share ($0.45)-($0.35).","Full-year 2024 outlook: revenue $2,635-2,735M, adj. EBITDA $350-390M, FCF $210-240M."],"urls":{"canonical":"https://secwatch.observer/filing/0001477449-24-000099","json":"https://secwatch.observer/filing/0001477449-24-000099.json","markdown":"https://secwatch.observer/filing/0001477449-24-000099.md","text":"https://secwatch.observer/filing/0001477449-24-000099.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1477449/000147744924000099/0001477449-24-000099-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1477449/000147744924000099/tdoc-20240425.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T07:50:40.899812+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ff248710f3825a8973c8eb344414533ae24d0097","claim":"Teladoc Health, Inc. reported three months ended March 31, 2024 results: revenue $646.1 million, net income $81.9 million net loss, EPS $0.49 per share. Guidance reaffirmed.","evidence_excerpt":"the three months ended March 31, 2023 (“First Quarter 2023”). Financial and Operational Highlights for First Quarter 2024 • First Quarter 2024 revenue grows 3% year-over-year to $646.1 million • First Quarter 2024 net loss of $81.9 million, or $0.49 per share • First Quarter 2024 adjusted EBITDA of $63.1 million, up 20% year-over-year “We are pleased to report a solid","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1477449/000147744924000099/0001477449-24-000099-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three months ended March 31, 2024"},{"label":"Revenue","value":"$646.1 million"},{"label":"Net income","value":"$81.9 million net loss"},{"label":"EPS","value":"$0.49 per share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}